Two years have passed since the Global AMR R&D Hub was launched in May 2018. During this time, the global partnership has expanded and the work of the Hub has progressed under three strategic pillars. Read more here..
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.